Sudarshan Pharma Industries Ltd — Important, 18-08-2026: Company Update

Sudarshan Pharma Industries released an investor presentation highlighting significant operational and strategic advancements. The company achieved global GMP and ISO 9001:2015 certifications for its Hyderabad manufacturing facility, enhancing its presence in regulated markets. Key acquisitions, including Ratna Lifesciences, demonstrate a successful turnaround, now showing strong profitability. Sudarshan Pharma also established a new R&D partnership with Amity University to drive innovation and product development. Financially, the company reported robust growth, with revenue from operations at 174.41 Cr and profit after tax at 5.61 Cr for the quarter. Exports are a strategic focus, targeting Rs. 100 Cr in FY26-27 through market diversification and high-value API products.